HTFL
Heartflow, Inc.
NasdaqGSUSDEQUITY
Healthcare
DELAYED
Buy
+47/100
Last price
50.70
▼ 1.51 (2.89%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
50.70
Prev close
52.21
Day high
54.32
Day low
49.51
Volume
2.91M
Market cap
$4.41B
P/E (TTM)
—
52W range
20.13 – 54.32
Day trading desk
Gap from prior close
-2.89%
Prior close 52.21
VWAP
—
—
Relative volume
0.00×
Quiet session
Session range
—
50.70 – 50.70
Position in range
—
—
ATR (14D)
2.55
5.03% of price
Prior day high
53.07
PDH
Prior day low
49.29
PDL
Bid / ask spread
—
Quote not published
Session volume
—
Avg 1.77M
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+1.73%
-0.2%
1M
+3.64%
+2.5%
3M
+93.84%
+89.3%
6M
+88.65%
+70.5%
YTD
+73.89%
+59.6%
1Y
+34.67%
+18.3%
3Y
—
-82.3%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on HTFL open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
-2.15M
Net selling
Buy transactions
14
236.93K shares
Sell transactions
18
2.39M shares
Net transactions
+32
Buys less sells
Sell : buy shares
10.1 : 1
Heavily one-sided
Insider-held shares
4.35M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Sep 18, 26 | ROGERS CAMPBELL M.D. Officer |
CONVERSION | 13.18K | $104.59K | Direct |
| Sep 18, 26 | ROGERS CAMPBELL M.D. Officer |
SELL | 19.68K | $987.05K | Direct |
| Sep 15, 26 | VERGHESE VIKRAM Chief Financial Officer |
SELL | 34.98K | $1.75M | Direct |
| Sep 11, 26 | FARQUHAR JOHN C. M. Chief Executive Officer |
SELL | 38.90K | $1.82M | Direct |
| Sep 8, 26 | VERGHESE VIKRAM Chief Financial Officer |
SELL | 6.64K | $332.21K | Direct |
| Sep 3, 26 | VERGHESE VIKRAM Chief Financial Officer |
SELL | 33.42K | $1.67M | Direct |
| Aug 21, 26 | FARQUHAR JOHN C. M. Chief Executive Officer |
SELL | 27.23K | $1.36M | Direct |
| Aug 18, 26 | FARQUHAR JOHN C. M. Chief Executive Officer |
SELL | 32.68K | $1.47M | Direct |
| Aug 17, 26 | ROGERS CAMPBELL M.D. Officer |
CONVERSION | 9.22K | $175.16K | Direct |
| Aug 17, 26 | ROGERS CAMPBELL M.D. Officer |
SELL | 9.22K | $380.10K | Direct |
| Aug 14, 26 | FARQUHAR JOHN C. M. Chief Executive Officer |
SELL | 15.56K | $607.77K | Direct |
| Aug 10, 26 | FARQUHAR JOHN C. M. Chief Executive Officer |
SELL | 22.56K | $638.73K | Direct |
| Jul 30, 26 | FARQUHAR JOHN C. M. Chief Executive Officer |
CONVERSION | 31.22K | $158.01K | Direct |
| Jul 27, 26 | VERGHESE VIKRAM Chief Financial Officer |
CONVERSION | 22.52K | $50.00K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BAIN CAPITAL LIFE SCIENCES INVESTORS, L.L.C. |
Beneficial Owner of more than 10% of a Class of Security | — | Sale |
BARABE TIMOTHY CRAIG |
Director | 188.23K | Conversion of Exercise of derivative security |
FARQUHAR JOHN C. M. |
Chief Executive Officer | 321.91K | Sale |
HEALTHCOR PARTNERS MANAGEMENT L.P. |
Beneficial Owner of more than 10% of a Class of Security | — | Conversion of Exercise of derivative security |
JONES MARIE L |
Officer | 32.18K | Stock Award(Grant) |
LIGHTCAP JEFFREY C |
Director | 6.99M | Conversion of Exercise of derivative security |
ROGERS CAMPBELL M.D. |
Officer | 225.50K | Conversion of Exercise of derivative security |
TANSEY CASEY M |
Director | — | Conversion of Exercise of derivative security |
VERGHESE VIKRAM |
Chief Financial Officer | 179.53K | Sale |
WELDON WILLIAM CONRAD |
Director | 243.93K | Conversion of Exercise of derivative security |
Fundamentals
Market cap$4.41B
Enterprise value$4.27B
Revenue (TTM)$212.07M
Gross profit$169.83M
EBITDA$-71.36M
Net income$-118.37M
EPS (TTM)$-0.24
Free cash flow$-33.61M
Total cash$162.55M
Total debt$27.13M
Book value / share$3.23
Shares outstanding86.95M
Float67.20M
Short % of float9.36%
Dividend yield0.00%
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E-197.01
PEG ratio—
Price / sales—
Price / book15.71
EV / revenue20.15
EV / EBITDA-59.87
Gross margin80.08%
Operating margin-27.93%
Profit margin-55.82%
Return on equity-154.23%
Return on assets-18.06%
Debt / equity9.70
Current ratio5.08
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|
| Total revenue | $176.03M | $125.81M | $87.17M | +39.9% |
| Operating revenue | $176.03M | $125.81M | $87.17M | +39.9% |
| Cost of revenue | $40.84M | $31.36M | $29.12M | +30.2% |
| Gross profit | $135.20M | $94.45M | $58.05M | +43.1% |
| Research & development | $64.92M | $43.52M | $35.85M | +49.2% |
| Selling, general & admin | $134.34M | $112.15M | $95.11M | +19.8% |
| Total operating expense | $199.26M | $155.67M | $130.97M | +28.0% |
| Operating income | -$64.07M | -$61.22M | -$72.91M | -4.6% |
| Net interest income | -$9.63M | -$18.70M | -$19.24M | +48.5% |
| Pre-tax income | -$116.87M | -$96.37M | -$95.11M | -21.3% |
| Tax provision | -$76.00K | $53.00K | $547.00K | -243.4% |
| Net income | -$116.79M | -$96.43M | -$95.66M | -21.1% |
| Net income to common | -$116.79M | -$96.43M | -$123.69M | -21.1% |
| Basic EPS | -3.17 | -1.20 | -1.94 | -165.0% |
| Diluted EPS | -3.17 | -1.20 | -1.94 | -165.0% |
| EBIT | -$101.69M | -$73.61M | -$70.41M | -38.2% |
| EBITDA | -$93.12M | -$65.51M | -$62.78M | -42.1% |
| Basic shares | 36.85M | 80.62M | 63.86M | -54.3% |
| Diluted shares | 36.85M | 80.62M | 63.86M | -54.3% |
| Line item | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|
| Cash & equivalents | $44.78M | $51.37M | $122.77M | -12.8% |
| Cash & short-term investments | $176.79M | $51.37M | $122.77M | +244.2% |
| Accounts receivable | $29.34M | $24.64M | $20.55M | +19.1% |
| Total current assets | $220.20M | $82.29M | $148.45M | +167.6% |
| Property, plant & equipment | $26.07M | $27.73M | $30.88M | -6.0% |
| Goodwill & intangibles | — | -$44.84M | -$40.59M | — |
| Total assets | $359.45M | $118.70M | $185.05M | +202.8% |
| Total current liabilities | $42.37M | $33.60M | $32.81M | +26.1% |
| Long-term debt | — | $136.43M | $134.01M | — |
| Total debt | $22.05M | $160.38M | $160.60M | -86.2% |
| Total liabilities | $58.80M | $978.19M | $962.62M | -94.0% |
| Retained earnings | -$1.09B | -$970.96M | -$874.53M | -12.0% |
| Shareholder equity | $300.65M | -$859.48M | -$777.56M | +135.0% |
| Working capital | $177.83M | $48.68M | $115.63M | +265.3% |
| Net tangible assets | $300.65M | -$859.48M | -$777.56M | +135.0% |
| Shares issued | 85.28M | 80.62M | 80.62M | +5.8% |
| Line item | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|
| Net income | -$116.79M | -$96.43M | -$95.66M | -21.1% |
| Depreciation & amortisation | $8.57M | $8.09M | $7.63M | +5.9% |
| Stock-based compensation | $13.96M | $10.21M | $11.87M | +36.7% |
| Change in working capital | -$7.66M | -$10.88M | -$8.54M | +29.6% |
| Operating cash flow | -$54.02M | -$69.00M | -$76.43M | +21.7% |
| Capital expenditure | -$5.03M | -$4.36M | -$6.11M | -15.3% |
| Investing cash flow | -$238.57M | -$4.36M | -$6.11M | -5,375.5% |
| Share buybacks | $0 | $0 | -$228.00K | — |
| Financing cash flow | $286.04M | $2.24M | $169.32M | +12,686.9% |
| Free cash flow | -$59.05M | -$73.36M | -$82.54M | +19.5% |
| End cash position | $49.48M | $55.84M | $127.23M | -11.4% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $64.08M | $52.59M | $49.13M | $46.28M | $43.42M | +21.9% |
| Operating revenue | $64.08M | $52.59M | $49.13M | $46.28M | $43.42M | +21.9% |
| Cost of revenue | $10.89M | $10.42M | $10.07M | $10.86M | $10.65M | +4.5% |
| Gross profit | $53.19M | $42.16M | $39.06M | $35.41M | $32.78M | +26.2% |
| Research & development | $26.26M | $21.62M | $18.66M | $17.30M | $15.03M | +21.5% |
| Selling, general & admin | $44.83M | $42.57M | $38.15M | $33.22M | $31.46M | +5.3% |
| Total operating expense | $71.09M | $64.19M | $56.81M | $50.51M | $46.49M | +10.8% |
| Operating income | -$17.90M | -$22.02M | -$17.75M | -$15.10M | -$13.71M | +18.7% |
| Net interest income | $2.31M | $2.46M | $2.63M | -$1.73M | -$5.99M | -6.3% |
| Pre-tax income | -$15.72M | -$27.36M | -$24.56M | -$50.83M | -$9.14M | +42.5% |
| Tax provision | $22.00K | $23.00K | -$165.00K | $30.00K | $59.00K | -4.3% |
| Net income | -$15.74M | -$27.38M | -$24.39M | -$50.85M | -$9.20M | +42.5% |
| Net income to common | -$15.74M | -$27.38M | -$24.39M | -$50.85M | -$9.20M | +42.5% |
| Basic EPS | -0.18 | -0.32 | -0.29 | -1.04 | -0.11 | +43.8% |
| Diluted EPS | -0.18 | -0.32 | -0.29 | -1.04 | -0.11 | +43.8% |
| EBIT | -$15.72M | -$27.35M | -$24.55M | -$47.37M | -$2.52M | +42.5% |
| EBITDA | -$13.46M | -$24.92M | -$22.31M | -$45.29M | -$373.00K | +46.0% |
| Basic shares | 86.40M | 85.64M | 84.83M | 49.11M | 80.62M | +0.9% |
| Diluted shares | 86.40M | 85.64M | 84.83M | 49.11M | 80.62M | +0.9% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $34.36M | $19.67M | $44.78M | $291.17M | $80.21M | — | +74.7% |
| Cash & short-term investments | $162.55M | $158.32M | $176.79M | $291.17M | $80.21M | — | +2.7% |
| Accounts receivable | $42.76M | $35.53M | $29.34M | $27.86M | $29.69M | — | +20.4% |
| Total current assets | $223.97M | $211.83M | $220.20M | $327.79M | $118.44M | — | +5.7% |
| Property, plant & equipment | $24.88M | $24.24M | $26.07M | $25.09M | $25.96M | — | +2.7% |
| Goodwill & intangibles | — | — | — | — | -$47.12M | -$46.01M | — |
| Total assets | $344.46M | $344.02M | $359.45M | $364.40M | $159.36M | — | +0.1% |
| Total current liabilities | $44.09M | $38.02M | $42.37M | $37.85M | $32.94M | — | +16.0% |
| Long-term debt | — | — | — | — | $182.42M | $179.66M | — |
| Total debt | $27.13M | $26.35M | $22.05M | $21.79M | $205.15M | — | +3.0% |
| Total liabilities | $64.74M | $58.31M | $58.80M | $109.83M | $1.05B | — | +11.0% |
| Retained earnings | -$1.13B | -$1.12B | -$1.09B | -$1.06B | -$1.01B | — | -1.4% |
| Shareholder equity | $279.73M | $285.72M | $300.65M | $254.57M | -$894.79M | — | -2.1% |
| Working capital | $179.88M | $173.81M | $177.83M | $289.94M | $85.50M | — | +3.5% |
| Net tangible assets | $279.73M | $285.72M | $300.65M | $254.57M | -$894.79M | — | -2.1% |
| Shares issued | 86.72M | 86.11M | 85.28M | 83.47M | 80.62M | — | +0.7% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Net income | -$15.74M | -$27.38M | -$24.39M | -$50.85M | -$9.20M | — | +42.5% |
| Depreciation & amortisation | $2.26M | $2.43M | $2.25M | $2.09M | $2.14M | — | -7.0% |
| Stock-based compensation | $7.91M | $6.55M | $5.26M | $3.96M | $2.25M | — | +20.7% |
| Change in working capital | -$2.41M | -$18.36M | -$1.70M | $6.63M | -$15.06M | — | +86.9% |
| Operating cash flow | -$8.58M | -$30.10M | -$10.60M | -$2.96M | -$27.30M | — | +71.5% |
| Capital expenditure | -$1.92M | -$1.89M | -$1.90M | -$1.24M | -$790.00K | — | -1.9% |
| Investing cash flow | $21.22M | -$1.43M | -$235.44M | -$1.24M | -$790.00K | — | +1,587.3% |
| Share buybacks | — | — | — | — | — | $0 | — |
| Financing cash flow | $2.05M | $6.16M | -$50.00K | $214.94M | -$1.77M | — | -66.7% |
| Free cash flow | -$10.50M | -$31.99M | -$12.49M | -$4.19M | -$28.09M | — | +67.2% |
| End cash position | $39.06M | $24.37M | $49.48M | $295.64M | $84.69M | — | +60.3% |
Options analytics
Put / call volume
0.02
Call-heavy session
Put / call open interest
0.10
Positioning, not flow
Max pain
45.00
-11.2% from spot
ATM implied vol
0.0%
Nearest strike to spot
Skew (10% OTM)
0.0%
Calls bid over puts
Call volume
3.04K
Contracts, this expiry
Put volume
73
Contracts, this expiry
Heaviest call OI
55.00
1.41K contracts
Heaviest put OI
45.00
138 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | -0.13 | -0.07 | +47.8% |
| Mar 2026 | -0.17 | -0.16 | +8.5% |
| Dec 2025 | -0.16 | -0.12 | +23.2% |
| Sep 2025 | -0.24 | -0.27 | -12.5% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | -0.10 | 9 | $65.26M | +41.0% |
| Next quarter | -0.09 | 9 | $66.81M | +36.0% |
| Current year | -0.42 | 9 | $248.93M | +41.4% |
| Next year | -0.26 | 9 | $309.04M | +24.1% |
Analyst targets & ownership
Mean target$46.00
High target$56.00
Low target$39.00
Implied upside-9.27%
Analyst count9
ConsensusBUY
Strong buy / Buy2 / 6
Hold2
Sell / Strong sell0 / 0
Held by insiders5.00%
Held by institutions91.87%
Institutions holding286
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
49.58
+2.25% from price
SMA 20
49.24
+2.94% from price
SMA 50
43.14
+17.50% from price
SMA 100
36.14
+40.28% from price
SMA 200
32.09
+57.96% from price
EMA 12
49.83
+1.75% from price
EMA 26
48.14
+5.31% from price
EMA 50
44.29
+14.46% from price
RSI (14)
59.5
Neutral
MACD (12,26,9)
1.69
Hist -0.31
ATR (14)
2.55
5.03% of price
Realised vol 30D
45.8%
Annualised
Bollinger upper
52.18
20, 2σ
Bollinger lower
46.30
20, 2σ
50 / 200 cross
Golden
43.14 vs 32.09
Trend bias
Above 200
+57.96%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
1.65
More volatile than market
Correlation to SPY
0.27
Largely independent
Realised vol 30D
45.8%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-48.7%
Peak to trough
Max drawdown 5Y
-48.7%
Peak to trough
ATR 14
2.55
5.03% of price
Beta (reported)
—
5Y monthly, from filing
Short interest
Shares short
5.63M
Prior 6.78M
Change vs prior
-17.0%
Shorts covering
% of float
9.36%
Normal
% of shares out
6.47%
Against total outstanding
Days to cover
2.6
Liquid
Float
67.20M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 22, 26 | Canaccord Genuity | MAINTAINED | Buy | Buy |
| Sep 9, 26 | UBS | INITIATED | — | Neutral |
| Aug 14, 26 | Canaccord Genuity | MAINTAINED | Buy | Buy |
| Aug 14, 26 | Morgan Stanley | MAINTAINED | Equal-Weight | Equal-Weight |
| Aug 14, 26 | Piper Sandler | MAINTAINED | Overweight | Overweight |
| Aug 14, 26 | JP Morgan | MAINTAINED | Overweight | Overweight |
| Aug 14, 26 | Wells Fargo | MAINTAINED | Overweight | Overweight |
| Aug 14, 26 | Stifel | MAINTAINED | Buy | Buy |
| Jul 31, 26 | Baird | INITIATED | — | Outperform |
| Jul 1, 26 | Freedom Capital Markets | INITIATED | — | Buy |
| May 15, 26 | Canaccord Genuity | MAINTAINED | Buy | Buy |
| May 15, 26 | Wells Fargo | MAINTAINED | Overweight | Overweight |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio—
Ex-dividend date—
Next pay date—
Last split—
Split date—
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-08-13
Corporate Changes & Voting Matters
8-K · 2026-06-18
Periodic Financial Reports
10-Q · 2026-05-14
Annual Report to Shareholders
ARS · 2026-04-29
Periodic Financial Reports
10-K · 2026-03-18
Corporate Changes & Voting Matters
8-K · 2026-01-12
Periodic Financial Reports
10-Q · 2025-11-12
Periodic Financial Reports
10-Q · 2025-09-19
Headlines
AI Cardiac Diagnostics Pioneer Sets HeartFlow (HTFL) for High-Margin Expansion
Insider Monkey · 8d ago
Heartflow Insider Sold Shares Worth $1,230,742, According to a Recent SEC Filing
MT Newswires · 16d ago
BCSM Exits Heartflow (HTFL) on Competitive Concerns
Insider Monkey · 20d ago
HeartFlow's CEO Sells 38,900 Shares for $1.8 Million After the Stock Hit a 52-Week High
Motley Fool · 22d ago
Heartflow Insider Sold Shares Worth $1,819,605, According to a Recent SEC Filing
MT Newswires · 22d ago
Heartflow Insider Sold Shares Worth $332,212, According to a Recent SEC Filing
MT Newswires · 27d ago
UBS Initiates Coverage on HeartFlow With Neutral Rating, $55 Price Target
MT Newswires · 28d ago
HeartFlow CFO Dumps Over 33,000 Shares for $1.7 Million as the Stock Hits a 52-Week High
Motley Fool · 31d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.